Computer aided detection CAD data analysis procedures are introduced and applied to derive composite diffuse optical tomography DOT signatures of malignancy in human breast tissue. In contrast to previous optical mammography analysis schemes, the new statistical approach utilizes optical property distributions across multiple subjects and across the many voxels of each subject. The methodology is tested in a population of 35 biopsy-confrmed malignant lesions. Methods: DOT CAD employs multiparameter, multivoxel, multisubject measurements to derive a simple function that transforms DOT images of tissue chromophores and scattering into a probability of malignancy tomogram. The formalism incorporates both intrasubject spatial heterogeneity and intersubject distributions of physiological properties derived from a population of cancercontaining breasts the training set. A weighted combination of physiological parameters from the training set defne a malignancy parameter M, with the weighting factors optimized by logistic regression to separate training-set cancer voxels from training-set healthy voxels. The utility of M is examined, employing 3D DOT images from an additional subjects the test set. Results: Initial results confrm that the automated technique can produce tomograms that distinguish healthy from malignant tissue. When compared to a gold standard tissue segmentation, this protocol produced an average true positive rate sensitivity of 89% and a true negative rate specifcity of 94% using an empirically chosen probability threshold. Conclusions: This study suggests that the automated multisubject, multivoxel, multiparameter statistical analysis of diffuse optical data is potentially quite useful, producing tomograms that distinguish healthy from malignant tissue. This type of data analysis may also prove useful for suppression of image artifacts.
I. INTRODUCTION I.A. Diffuse optics and automated cancer diagnosis
Diffuse optical spectroscopy DOS utilizes light in the low absorption window 1 between 650 and 950 nm to measure chromophore concentrations and scattering in deep tissues. Information about concentrations of water, lipid, oxy HbO 2 , deoxy Hb, and total hemoglobin Hb t , as well as blood oxygen saturation StO 2 , and tissue scattering i.e., subject spatial heterogeneity and intersubject distributions of physiological properties derived from a population of cancercontaining breasts the "training set". We extract a weighted combination of physiological parameters from the training set to defne a "malignancy parameter" M, with the weighting factors optimized to separate training-set voxels from healthy and cancerous tissue. We then examine the utility of M, employing 3D DOT images from an additional subject the "test set". the reduced scattering coeffcient, are readily derived s with the optical techniques.
Diffuse optical tomography DOT utilizes many point measurements on the surface of tissue to reconstruct concentrations of chromophores and scattering parameters in the interior of the tissue. Images are obtained by inverting the heterogeneous diffusion equation. A recent review by Arridge and Schotland 2 describes various techniques needed to perform this inversion. The results are three-dimensional 3D maps of optical properties and chromophore concentrations. The reconstructed parameters have been correlated with the physiological signatures of tumors. For example, optically measured Hb t has been correlated with microvessel
I.B. Limitations of current diffuse optics analysis
To better appreciate the need for DOT CAD, consider the typical analysis scheme currently employed in the feld. First, the lesions in each subject are identifed, then tissue is divided into "healthy" and "lesion" regions, and average optical properties are computed for each region. Finally, these regionally averaged optical properties and differences thereof are assessed across the population. With this approach, the spatial information from DOT images is reduced to a few numbers. Such an analysis implicitly ignores the spatial heterogeneity of cancers [11] [12] [13] and healthy tissues.
14 density measured by histopathology, 3 and s lated with cellular volume fraction and mean size. 4 Leff et al. 5 recently reviewed DOT breast tumor contrasts in Hb t and StO 2 . Some disagreements remain in the diffuse optics community about which optically measured parameters are the most important indicators of malignancy; recent work, for example, on water 6 and collagen 7 has opened up additional has been correGrand averages of DOT data across multiple studies suggest that malignant lesions can be differentiated from healthy tissue by Hb t . 5 In recent work 15 using the same data set as in the analysis to be presented herein, we performed such regional averaging from DOT images; we then demonstrated that benign and malignant lesions could be separated with a univariate analysis of the ratio of the mean lesion and possibilities.
While current incarnations of multiwavelength DOT provide 3D images of several physiological parameters associated with cancer metabolism and growth, unambiguous 3D maps of healthy and malignant tissue are sometimes elusive. DOT images require simultaneous interpretation of multiparameter data at each spatial point, and images sometimes exhibit signifcant inter-and intrasubject variation in the absolute and relative values of these parameters. Together, these factors limit DOT image analysis to skilled practitioners of the art. In this contribution, we address this issue. In particular, we introduce a novel algorithm for automated identifcation of malignant and healthy tissue based on a statistical analysis of diffuse optical data from a population of known cancers.
The requirement for skilled readers is not unique to optics; most clinical imaging technologies have similar constraints and various techniques for automated breast cancer detection and diagnosis have been explored to ameliorate this situation. Notably, computer-aided detection CAD in x-ray mammography screening relies upon high-spatialresolution 2D intensity projections to automatically identify tumors in images based on structural features such as spiculation and microcalcifcation. [8] [9] [10] The formalism presented herein for DOT CAD employs multiparameter, multivoxel, multisubject measurements to derive a simple function that transforms DOT images of tissue chromophores and scattering into a "probability of malignancy" tomogram. The formalism incorporates both intrahealthy tissue values of Hb t , s s work found that the benign and malignant lesions had a statistically signifcant different ratio of the Hb t region means e.g., Hb t Lesion / Hb t Healthy .
Volume element histograms of rHb t Hb t / Hb t Healthy reveal more information than distribution means. Histograms of two subjects are shown in Fig. 1 . Figure 1a shows an optimal subject wherein the lesion is clearly distinguishable from healthy tissue. Figure 1b shows a problematic subject; here, variations in the healthy region which include possible image reconstruction artifacts extend the distribution of healthy tissue rHb t into the range of cancer tissue rHb t . The frst lesion Fig. 1a can be readily identifed with the simple normalization procedures described above and a cutoff of rHb t = 1.2. The same procedure and cutoff for case two Fig. 1b , however, would miss the cancer completely; furthermore, adjustment of the cutoff to include the tumor causes incorrect assignment of some healthy regions. These observations suggest a more sophisticated analysis using all available spatial information is desirable. Additionally, simple thresholding in a single optical parameter ignores the potential utility of multiparameter data and ignores possible spatially heterogeneous signatures of cancers and healthy tissues.
Thus far, a few groups applied statistical analysis techniques to multiparameter optical measurements, including applications to arthritic joints, 16 high-risk 17 or high mammographic density 18 The left column a shows a lesion with clearly separated means and distinct distributions; and the right column b shows a subject wherein the healthy Hb t distribution overlaps that of the cancer region. This normalization approach is standard in the "typical" DOT analysis, and the example is taken from our previous work Ref. 15 . Note that the "typical DOT" scheme shown in the fgure utilizes a normalization that is different from Eq. 1.
scopic" measurements or excised tissues. 20 The data sets employed thus far, however, have limited spatial information and orders of magnitude fewer measurements per subject than, for example, the breast tomograms utilized in the analysis to be presented herein. A few researchers implemented automated image methods with DOT to identify lesions in a particular subject. [21] [22] [23] This per-subject analysis, however, neglects information about the common signatures of cancer across a population. Still other researchers pursued hypothesis-driven multiparameter optical metrics with DOS 24, 25 and DOT. 15, 26 Such metrics are dependent on the underlying hypotheses, however, and are often empirically chosen combinations of equally weighted parameters. Chance et al. 27 explored two-parameter signatures of breast cancer, graphically identifying malignant lesions, but the separation lines were manually selected for the specifc data set.
Thus, previous studies fall into two groups. Some considered spatial variation in cancers, but neglected common signatures across a population. Others considered population signatures, but used only regionally averaged measurements. Furthermore, few, if any, applied statistical optimization techniques to multiparameter optical signatures of cancer across a population. By contrast, the methods we present herein utilize data from many voxels in many subjects to statistically optimize a multiparameter probability of malignancy. 
II. METHODS

II.A. Data set used in this analysis
Our data set consists of 3D tomograms of total hemoglobin concentration Hb t , blood oxygen saturation StO 2 , and reduced scattering coeffcient in 35 biopsy-confrmed s cancer-bearing breasts. DOT images from these subjects were collected with a parallel plate optical imaging system described in previous works. 15, 36 37 Note, for each parameter, traditional regional averaging analysis of these data, as described above, reduces these 5 10 4 data points per subject to two numbers cancer and healthy region averages. Figure 1 shows sample intrasubject spatial heterogeneity of these regions, and Fig. 2a plots the distribution of Hb t for the healthy regions of all subjects.
We demonstrate the new statistical analysis method with a leave-one-out cross-validation e.g., as described by Hastie et al. 28 , in which 34 out of our 35 subjects serve as the training set and the remaining subject provides the test data. Permuting these sets, such that each subject serves as the test set once, provides 35 training/test data combinations and enables estimation of classifcation accuracy. Note that gold standard segmentation of the DOT images into tumor and healthy regions is required for the training set to train the classifer i.e., for the logistic regression model and is required for the test set classifcation validation i.e., to assess how well the classifer performed compared to the gold standard in a new data set. Both training set normalization described below and testing of our method require "gold standard" spatial localization of the cancers; a full description of the procedure utilized to identify cancer regions is given in Ref. 15 and the right fgure b shows the population distribution of zHb t after intrasubject normalization see Eq. 1 and note that each subject is normalized individually. Each trace represents the healthy region of one subject. For clarity of presentation, the vertical axis is normalized to the total number of voxels in each subject.
for a region-growing algorithm to identify the spatial extent of the tumor. A 2 cm border region about the tumor and voxels within 1 cm of the source and detector plane was excluded from the training data; the remainder of the breast is defned as healthy tissue. We exclude these boundary regions to reduce the effect of physiological changes near the tumor, errors in tumor positioning, and optode artifacts. In the training set, we assume perfect segmentation into malignant and healthy tissue. In the test set, gold standard segmentation is used only to determine the accuracy of our malignancy prediction.
II.B. Algorithm to calculate probability of malignancy
The image analysis has two parts: First, we determine the probability of malignancy function based on the population of known cancers. Then, we test the resulting function on another data set. We iterate this process, exchanging members of the training and test sets to improve the generalizability of our results.
We chose Hb t , StO 2 , and as our fundamental physis ological variables. We also tested the combination of Hb, HbO 2 , and , but little difference was found results not s shown. A schematic of the normalization, analysis, and testing protocol is given in Fig. 3 .
II.B.1. Intrasubject normalization
The frst step of this analysis is to normalize the tomographic data across the training sample, as distributions of optical properties vary signifcantly between subjects. We carry out this procedure for each physiological parameter in both healthy and cancer tissues. To illustrate, consider the total hemoglobin concentration, Hb t . Figure 2a shows the reconstructed Hb t for all healthy tissue voxels in all subjects. We see that the spread of Hb t values is quite large, complicating the use of these data across the sample. Therefore, for each subject, we compute X =lnHb t , the healthy tissue mean X H , and the healthy tissue standard deviation X H . Note that X H and X H are calculated individually over the healthy regions in each subject, thereby capturing both interand intrasubject tissue heterogeneity. A similar set of data i.e., X =lnHb t is obtained for malignant tissue in each subject in the training set. Together, these quantities permit calculation of the "Z-score" for each variable in each voxel of each subject, e.g.,
Here, the subscript index d = H , M specifes healthy H and malignant M regions; the superscript index s =1:N s , specifes a subject in the training set, and the superscript index k =1:N s,d specifes voxel number within the healthy or mav lignant region in each subject. Note that the Z-score for both the healthy and malignant regions depends on the mean and standard deviation of the healthy region.
After the Z-score procedure, the distributions of physiological parameters in each voxel across subjects in the sample are much more similar. Figure 2b shows this for Hb t in the healthy regions across 35 subjects. Note that this intrasubject normalization brings the intersubject voxel chromophore distribution close to a zero-centered Gaussian distribution, permitting us to more sensibly combine data across multiple subjects.
A particularly attractive feature of this data normalization is the explicit inclusion in the normalized variable of the Test Accuracy of P M subject-dependent characteristic spatial fuctuations in each parameter via the distribution width X H . Previous work in the feld e.g., as reviewed by Leff et al. 5 used only the ratio of cancer to healthy values for each parameter; the previous approach accounts for the wide variation in mean parameter values between subjects, but ignores the differences in optical parameter distribution widths found in each subject's healthy tissue. With the normalization scheme described here, lesion contrast is scaled to the variation in healthy tissue. Similarly, we compute the Z-score for StO 2 and . s For the remainder of this paper, we will be computing and manipulating the normalized physiological variables:
N = N v = 40. Therefore, the same number of voxels ranv domly selected from each region and each subject is used for the next level of our analysis. We chose N v = 40 because the smallest tumors in our data set had 140 voxels and our analysis scheme depends on independent measurements from each voxel. With this choice for N v , the median voxel separation in the 35 tumor regions was 1.2 cm. We therefore do not expect spatial correlation due to DOT resolution to strongly affect results by reducing the independence between measurements. 
Drawing N v = 40 voxels from the tumor and healthy regions in each of 35 subjects provides a set of 1400 tumor and 1400 healthy voxels defned by our gold standard segmentation. We utilize this set of voxels in our leave-one-out protocol, removing all voxels of the test subject from the total data set so that the remaining 1360 voxels from each region serve as the training set for classifcation. The trained classifcation rule is then applied to the test set to predict malignancy. The entire procedure is then repeated for the other test subjects.
Choosing an equal number of voxels from each region improves our estimate of the accuracy of our classifcation technique under the leave-one-out cross-validation protocol, which will be discussed in Sec. III.
II.B.2. Training set analysis procedure
The tomographic data of all subjects in the training set, i.e., data from all chromophores in N v voxels of the healthy and malignant regions of each of N s subjects, are combined into a single matrix. Using a logistic regression model with the known malignancy status of each voxel as the outcome and the normalized tomographic data as predictors, we ft a weight vector = zHb t , zStO 2 , z , 0 and compute the test subject is also shown in Fig. 1a ; note the improved separation between the malignant and healthy regions.
s,k
In forming M d , we thus account for measurements taken across multiple subjects and measurements taken across multiple spatial locations in each subject. The right most column of 1's in the Z-matrix relates to 0 and introduces an offset that could, in principle, include effects from additional parameters e.g., variations in tissue fat content, age, etc. not considered in the present analysis see Refs. 29 and 30 for more details on this latter point.
From M, we compute a probability of malignancy using the function
Our goal is to identify a weighting vector that maximizes the difference in probability between voxels in healthy Fig. 4 for typical training and test sets.
II.C. Test subject normalization
The output from the logistic regression described in Sec. II B 2 is the parameter weighting vector, , which we then apply to data from an independent test subject i.e., DOT data from the "leftover" subject. Such an application derives a predicted probability of malignancy for each voxel in the test subject.
Normalization of the test data set is slightly more complicated than that of the training data, as we must not assume knowledge of the cancer location in the test subject's breast. We therefore empirically defne the healthy region as those voxels in which both Hb t and lie within the whole-breast s mean and the whole-breast mean plus 2 standard deviations.
Training Data Training Data
Note that the results turned out to be only mildly sensitive to . Example probability of malignancy PM calculated for two test subjects. The function PM blue line is derived from the training set, as described in Sec. II B 2. This function is then applied to the remaining test subject in each case; using the gold standard segmentation described in Sec. II A, voxels are labeled as healthy green crosses or malignant red dots. Image slices from the same subjects are shown in Fig. 6 . For clarity, only every hundredth voxel is plotted. a Typical invasive cancer that shows very good separation between healthy and malignant regions. b Case study: In situ lesion; this lesion is not as well separated from the background healthy tissue. PM for this in situ lesion is more heterogeneous, with a lower average than the invasive lesion and more overlap between malignant and healthy tissue. Figure 5 shows P vs M for two subjects; example slices through the center of the cancers for the same subjects are shown for rHb t Fig. 6a and PM Fig. 6b . A probability cutoff is readily applied to the data i.e., a horizontal line in Fig. 5 in order to provide a concrete criterion to create spatial masks of regions that are highly suspicious for malignancy Fig. 6c . One can then compare these masks to the gold standard malignant and healthy regions for each test subject.
III. RESULTS
To quantify the quality of probability maps, such as those shown in Fig. 6b lignant regions across the entire set of test subjects; for this task, we use the same randomly selected voxels, as described in Sec. II B 1. Figure 7a shows a histogram of M drawn from test subject healthy and malignant regions in each iteration of the leave-one-out protocol; Fig. 7b is a box plot of the PM distributions. Notice that the voxels from the tumor region are distributed narrowly about PM 1, but the distribution has a small tail of outliers. Similarly, the healthy region voxels are concentrated near PM 0.1, but the central quartiles of the distribution extend from 0.01 to 0.2 and the fourth quartile extends to 0.6, with outliers up to 1. This wide distribution of values in the healthy region can also be seen in Fig. 5 .
We next impose a probability of malignancy cutoff, P cut : Voxels with probability above P cut are predicted to be malignant, those below P cut are predicted to be healthy. Finally, we compare this prediction to the gold standard diagnosis. For each value of P cut , some test subject voxels are malignant this determines how many cancers are missed. With the sample used in this analysis, a probability cutoff of P cut = 0.95 yields FNR of 11%. At the same cutoff, 89% of the voxels predicted to be cancerous are correctly classifed TPR and 6% of the voxels in the healthy region are incorrectly predicted to be cancerous FPR, while the remaining 94% of the healthy region voxels are correctly labeled. The cutoffs can be tuned to suit particular clinical needs see insets in Fig. 8 for classifcation rates corresponding to other values of P cut .
Since the Z-score is in "units" of standard deviation, we can directly compare the magnitudes of the derived coeffcients to determine the relative importance of each parameter for identifying malignancy. Averaging over 35 combinations of 34 subjects in the training set gives, and correctly predicted to be malignant true positive TP; = 2.68 0.12, 37 suggesting that of the three optical params s dicted to be healthy false negative FN; some test subject malignancy. It should be noted that the weights are coeffvoxels are healthy, but incorrectly predicted to be malignant cients derived from a logistic regression model and can be false positive FP; and some test subject voxels are healthy interpreted precisely in terms of changes in the log odds of eters, the difference in offers the strongest evidence of some test subject voxels are malignant, but incorrectly preand correctly predicted to be healthy true negative TN.
These quantities can be expressed as rates by dividing each of these classifcations by the total number of voxels in the healthy or malignant regions. We can thus calculate true and false positive rates TPR= TP/ TP+ FN , FPR =FP/ TN+ FP and true and false negative rates TNR =TN/ TN+ FP , FNR= FN/ FN+ TP as functions of P cut . The receiver operator characteristic ROC curve plots TPR against FPR; ROC curves are shown in Fig. 8 . Note that these quantities are often referred to as sensitivity TPR and specifcity 1 − FPR. Rates are averaged over 35 permutations of our training/test subjects. Average TPR, FPR, FNR, and TNR across all test subjects for several values of P cut are tabulated in the insets of Fig. 8 .
For the purposes of cancer detection, FNR is critical, as malignancy. For example, a one unit change in z s an estimated 2.7-fold increase in the log odds of malignancy for that voxel or, equivalently, a 14.9-fold increase in the odds of malignancy. However, when is calculated across all 35 subjects, we fnd the signifcance "p value" of each element in to be 0.005, suggesting that all three parameters should be retained in the model. The analysis described above assumes that each 2 2 2 mm voxel in the 3D tomogram is independent of the others. However, it is well known that the spatial point spread function of light transport in tissue limits DOT spatial resolution to 0.5-1 cm Refs. 32-35 in breast tissue at biological contrast levels. Furthermore, there are likely to be physiological correlations between different spatial locations in the breast e.g., all voxels drawn from adipose tissue. We 11 explored a simple model of correlated voxels, in which we identifed "clumps" of the same size as the tumor in each breast and then compared the average value of the probability of malignancy in these clumps to that of the tumors. Interestingly, we found the distribution of PM to have fewer outliers than Fig. 7 and values in the confusion matrix to be within 5% of the per-voxel values presented in the insets of Fig. 8 at P cut = 0.95.
IV. DISCUSSION
This study suggests that multisubject, multivoxel, multiparameter statistical analysis of diffuse optical data is potentially quite useful. Using a relatively simple statistical classifcation approach, we have reproduced most of the results described in Ref. 15 . Furthermore, a lengthy analysis by a skilled researcher was not required and several different cancer types were included see Table I . Initial results also suggest that this type of data analysis may be useful for suppression of image artifacts, but we have not yet systematically studied the issue. Interestingly, in the small number 3, see Table I of in situ cancers contained in our sample, we have noted a lower value of the malignancy parameter M than for the more common invasive cancers see Fig. 5 for an example.
tumors from our data set. The smallest tumor included in the sample has a total volume of 1.1 cm 3 139 voxels. The median separation between the N v = 40 randomly chosen voxels in this tumor is 0.85 cm with an interquartile range IQR of 0.71 cm; this separation is within the expected 0.5-1 cm resolution of the optical reconstruction technique. For comparison, in the same subject, the median separation in the N v = 40 healthy tissue voxels was 4.5 cm and the IQR 3.5 cm. We then repeated the leave-one-out protocol described above on a sample of the 31 subjects with tumor volume greater than 2 cm 3 250 voxels. We found that the classifcation rates at P cut = 0.95 changed very little i.e., 1%. Furthermore, remained consistent within our calculated error. We also tested the possibility of overweighting small tumors through correlated measurements by extracting a fxed percentage 10% of the total tumor voxels from each subject and using 10% of the total tumor voxels, up to a maximum of 40. These shifts in the training set selection changed the classifcation rates at P cut = 0.95 by only 2%. Alternately, we could select voxels from a sparse grid in the tissue regions to enforce a consistent or minimal voxel separation.
To test the effects of our random voxel selection, we repeated our analysis on the data sample fve times, randomly selecting new training voxels with each iteration. The standard deviations of extracted from the entire training set z zHb t zStO 2 , and In Sec. III, we noted s is the most important parameter for identifcatherefore z s tion of malignancy, followed by zHb t . The value of z =2%, =6%, = 11%, and = 29%. 0 were and s zHb t differed little between training sets. zStO 2 , on the other hand, was both smaller than the other coeffcients and had a much larger variation between subjects 20% vs 5%. StO 2 is thus less important for differentiation of malignant regions in this data set, an observation consistent with earlier results. 15 This preliminary study has several limitations. The most signifcant limitation is its small sample size. The current analysis uses a "leave-one-out" protocol. Future work with larger samples will use "leave-M-out," for M 1, a better approach to probing the generalizability of the method.
A more subtle issue that deserves further exploration was our assumption that each voxel used in the training is independent. As we discussed at the end of Sec. III, we expect spatial correlations from both biological sources and reconstruction artifacts from DOT mammography. The logistic regression classifcation scheme assumes independent measurements; future work will utilize more sophisticated classifers to take advantage of the biological correlation e.g., between voxels from glandular tissue and minimize the effects of correlation arising from DOT e.g., resolution limits. The use of correlated measurements in the training set will result in underestimation of the variance in ; however, our classifer does not use this variance: We only apply the point estimate of , which is unbiased even when the data are correlated, to the test set. Therefore, the classifcation rates remain valid even though we did not explicitly take into account potential correlation between adjacent voxels.
We also explored possible effects on this analysis technique from DOT resolution limits by eliminating the smallest s Recall that zStO 2 had the smallest magnitude and most variation between different training sets 20%.
Another potential source of error is the imperfect tissue segmentation we relied upon as the gold standard for assignment of each voxel as healthy or cancerous. This segmentation relies upon both nonconcurrent clinical imaging e.g., MRI to locate the tumor and a region growing algorithm on each subject's optical tomogram to defne the tumor boundaries, therefore potentially introducing discrepancies in the tissue segmentation. We excluded a 2 cm thick boundary region about each tumor from the corresponding healthy region to reduce effects of errors in spatial localization of the tumor boundary on the training healthy tissue data.
Although the analysis includes more spatial data than typically used, most of the data were still discarded, i.e., N v =40 4.5 10 4 voxels drawn from the healthy region in each subject. We chose this limit for data selection in order to weight tumor and healthy regions equally and take only 30% of voxels from the smallest tumors. Furthermore, this choice permits a more intuitive interpretation of PM and improves quantifcation of classifcation accuracy. We are currently exploring other weighting schemes which permit use of all or most of the healthy tissue voxels. Additionally, no healthy subjects or benign lesions were included in the present sample; inclusion might raise false positive rates, as the relative optical properties of some benign tumors overlapped those of cancers in our previous work. 15 Logistic regression is a fairly simple binary classifcation scheme, which permits use of both continuous and classifcation variables. The analysis presented here did not include zHb t zStO 2 z other classifcation variables menopausal status, age, etc., as our total sample is fairly small. For the same reason, we did not attempt to separate cancer types; we will apply such analysis to larger samples in future work. More sophisticated classifcation techniques, for example, could include more than two output categories e.g., image artifact, malignant, benign, and healthy regions; again, suffciently large data sets will permit us to differentiate between types of benign and malignant lesions. Additionally, we will apply a variation in this technique to larger samples e.g., nonimaging studies of many subjects and more complete data sets e.g., concurrent optical/MR imaging. Finally, future work will implement classifcation approaches such as support vector machines or neural networks that have demonstrated better predictive capability in other applications, as in Klose et al.
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V. CONCLUSION
The potential for population-based statistical image processing of diffuse optical data using logistic regression of three optically measured physiological parameters Hb t , StO 2 , and and a leave-one-out paradigm for 35 subjects s was demonstrated. Our voxel-level diagnosis produced an average TPR of 89% and FPR of 11% with no human interpretation of test data set required. These results are a starting point for development of diffuse optical tomography CAD algorithms. Such multiparameter optical signatures of cancer may enhance the utility of an adjunct or standalone optical device in the clinical imaging environment.
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